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Abstract — Mitochondria are the main site of energy power in eukaryotic cells. The enzyme F
O
F
1
 synthase is 
responsible for ATP production driven by the transmembrane proton gradient. The maintenance of a very low 
permeability of the inner mitochondrial membrane is crucial for this mechanism, since sudden opening of the 
permeability transition pore (PTP) leads to matrix swelling and outer membrane rupture, with release of pro-
apoptotic factors. Recently, it has been suggested that dimers of ATP synthase in mammals could represent the 
main component of the mitochondrial PTP, a feature modulated by calcium and involving the matrix protein 
Cyclophilin D (CyPD). This study would help to develop new tools for the identification of plant secondary 
metabolites, in particular flavonoids, able to modulate PTP and therefore acting on the programmed cell death 
mediated by mitochondria. Therefore, this project would represent the first screening for plant molecules able 
to interfere with programmed cell death, as a preliminary study for the development of drugs active in PTP-
related pathologies.
Index Terms — TRANS2CARE, Cyclophilin ATP synthase, permeability transition pore, programmed cell death, 
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1 BACKGROUND
Mitochondria are double-membrane organelles, which represent the energy power of eukaryotic 
cells. In aerobic conditions, the production of ATP in mitochondria is exerted by FOF1 ATP synthase. 
Nevertheless, mitochondria are also involved in the early stages of programmed cell death (PCD) 
through the release of pro-apoptotic factors from the intermembrane space. Such a release can be 
due to a sudden opening of the inner mitochondrial membrane permeability transition pore (PTP) to 
small molecules. This implies a matrix swelling, leading to outer membrane rupture and release of pro-
apoptotic factors. Recently, it has been proposed that ATP synthase, when present as a dimer, forms 
the mitochondrial PTP in the presence of high calcium concentration (Bernardi, 2013). Consistently, the 
modulator of permeability transition, the matrix protein Cyclophilin D (CyPD), has been identified also 
as ATP synthase interaction factor (Giorgio et al., 2009). 
Evidence of PTP formation by ATP synthase dimers has been obtained in mammalian mitochondria 
(Giorgio et al., 2013), although the underlying mechanisms remain to be established. Furthermore, 
little information is available for PTP in other organisms, where mitochondria are involved in PCD, in 
particular in plants (Vianello et al., 2012).
2 OBJECTIVES
This research will contribute to clarify the enzymatic mechanisms that allow the switch of ATP synthase 
to PTP formation and the physiological effectors involved in this process. Potential compounds, such 
as plant secondary metabolites (e.g. flavonoids), which could interfere with PTP formation will be 
identified. Then, their ability to modulate PCD pathway, mediated by mitochondria, will be examined. 
This would represent a preliminary step for the development of drugs active in PTP-related pathologies 
(tumors, ischemia, neurodegenerative diseases).
3 APPROACH & METHODS
General approach
The structural and functional properties of ATP synthase from different origins will be compared to 
define the essential elements involved in the process. This will constitute the basis for the following 
step in which molecules, able to modulate the PTP/ATP synthase switch activity, will be identified.
Methods
The structural and functional characterization of the ATP synthase will be performed by proteomic and 
immunological approaches. The mammal model will be used for comparison with ATP synthase from 
plant mitochondria. PTP formation will be followed by spectrophotometric and fluorimetric assays. The 
role of essential components of ATP synthase for PTP formation will be tested by knock-out mutants 
of Arabidopsis. The potential modulators of ATP synthase switch to PTP in both mammalian and plant 
mitochondria will be tested by fluorimetric techniques.
4 RESULTS
Dimerization of ATP synthase has been characterized in mammalian mitochondria by biochemical 
approaches, such as native electrophoresis, immunoblotting and enzymatic activity detected in 
situ (Giorgio et al., 2009). Identification of ATP synthase interaction factors has been performed by 
immunoprecipitation and cross-linking agents. It has been demonstrated that ATP synthase dimers 
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interact through the lateral stalk (OSCP subunit) with the matrix protein Cyclophilin D (CyPD), which 
is a well-known inducer of PTP closure, and such interaction is weakened by PTP-blocker Cyclosporin 
A (CsA) (Fig. 1) (Giorgio et al., 2009; 2013). Moreover, when isolated ATP synthase dimers were inserted 
into planar lipid bilayer, electrophysiological measurements demonstrated that, in the presence of 
calcium, they are able to form a channel with properties identical to those described for PTP (Giorgio et 
al., 2013). A hypothetical model of ATP synthase transition to PTP has been then formulated (Bernardi, 
2013) (Fig. 2).  
Plant mitochondria possess a similar active ATP synthase complex, but it has not been associated to 
PTP formation yet. Nevertheless, some components have been identified, such as OSCP and CyPD, but 
it is still not clear if they could interact in PTP modulation. 
Figure 1: CyPD interacts with mitochondrial ATP 
synthase through the lateral stalk connecting 
FOF1. ATP synthase from mammalian mitochondria 
was separated by SDS-polyacrylamide gel 
electrophoresis and immunodetected with Ab 
against CyPD, before (lane 1) and after treatment 
with the crosslinker DTBP in absence (lanes 2 
and 3) or presence of DTT (lanes 4 and 5) able to 
revert the effect. The 90 kDa crosslinked proteins 
(arrow) reacted also with Ab against the lateral stalk 
subunits of ATP synthase (not shown) (modified 
from Giorgio et al., 2009). 
Figure 2: Hypothetical transition of FOF1 
ATP synthase dimers to form the PTP. 
ATP synthase dimers can undergo PTP 
formation when Ca2+ rather than Mg2+ is 
bound, possibly at the catalytic sites, in 
a reversible process favored by binding 
of CyPD to OSCP. Adenine nucleotides 
counteract PTP formation in synergy with 
Mg2+. Red arrow denotes the hypothetical 
pathway for solute diffusion between two 
FO subunits (adapted from Bernardi, 2013). 
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5 POTENTIAL NEW PRODUCTS & SERVICES
This study will allow the identification of plant secondary metabolites (i.e. flavonoids) able to modulate 
ATP synthase switch to PTP. This would represent the first screening toward the realization of potential 
natural pharmaceuticals/drugs able to interfere with programmed cell death. Furthermore, the analysis 
of the components involved in ATP synthase activity and regulation would lead to identify proteins 
correlated to PCD. Their quantification in different organisms/tissues by immunological/proteomic 
techniques would lead to design diagnostic tools for PTP-related pathologies.
6 CURRENT COLLABORATIONS
6.1 With other researchers 
University of Padova, Department of Biology, Department of Biomedical Sciences; University of Udine, 
Department of Food Sciences; University of Trieste, Department of Life Sciences (LP, Trans2Care).
7 CONTACT OR COLLABORATIONS NEEDED
Future collaboration with clinical laboratories is needed.
8 COMMUNICATION TOOLS
• The high level of expertise in the field of biochemistry, as well as the high level of applicability, quality 
and performance of the presented research will be disseminated through high quality scientific 
publications.
• This research has been presented to the biomedical community at National and International 
congresses.
9 FUNDS NEEDED
9.1 For  basic research (investigation of biological mechanisms): € 40,000
9.2 For applied research (solutions for real-world problems): € 100,000
9.3 For pilot & demonstrator activities (to develop a prototype): € 150,000
10 CONCLUSIONS
The mitochondrial permeability transition is an essential event in mediating the early stage of the PCD 
pathways. The recent evidence of ATP synthase involvement in PTP formation opened an innovative 
and still unexplored research field to find agents able to modulate the PTP. This investigation would 
open new opportunities to identify plant natural products able to interfere with the PTP phenomenon 
and therefore would represent the first step to design diagnostic tools for PTP-related pathologies, 
which comprise a wide range of human diseases.
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